GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Equity-to-Asset

Vectus Biosystems (ASX:VBS) Equity-to-Asset : 0.74 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vectus Biosystems's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$2.37 Mil. Vectus Biosystems's Total Assets for the quarter that ended in Dec. 2023 was A$3.21 Mil. Therefore, Vectus Biosystems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.74.

The historical rank and industry rank for Vectus Biosystems's Equity-to-Asset or its related term are showing as below:

ASX:VBS' s Equity-to-Asset Range Over the Past 10 Years
Min: -19.23   Med: -0.64   Max: 0.83
Current: 0.74

During the past 8 years, the highest Equity to Asset Ratio of Vectus Biosystems was 0.83. The lowest was -19.23. And the median was -0.64.

ASX:VBS's Equity-to-Asset is ranked better than
58.34% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs ASX:VBS: 0.74

Vectus Biosystems Equity-to-Asset Historical Data

The historical data trend for Vectus Biosystems's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Equity-to-Asset Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Equity-to-Asset
Get a 7-Day Free Trial -19.23 -1.88 -0.47 -0.90 0.76

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.29 -0.90 0.83 0.76 0.74

Competitive Comparison of Vectus Biosystems's Equity-to-Asset

For the Biotechnology subindustry, Vectus Biosystems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Equity-to-Asset falls into.



Vectus Biosystems Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vectus Biosystems's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=3.524/4.63
=

Vectus Biosystems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2.37/3.207
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems  (ASX:VBS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Vectus Biosystems Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines